机构

• 高能物理研究所 [85]
• 上海药物研究所 [64]
• 近代物理研究所 [32]
• 国家天文台 [9]
• 上海天文台 [3]
• 大连化学物理研究所 [2]
• 更多

采集方式

• OAI收割 [127]
• iSwitch采集 [86]

内容类型

• 期刊论文 [206]
• 会议论文 [7]

发表日期

• 2023 [1]
• 2022 [1]
• 2021 [13]
• 2020 [7]
• 2019 [38]
• 2018 [11]
• 更多

学科主题

• Biodiversi... [1]
• Electroche... [1]
• Environmen... [1]
• Neuroscien... [1]
• Physics [1]
• 天文和天体物理 [1]
• 更多

筛选

浏览/检索结果: 共213条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 A Spectral-timing Study of the Inner Flow Geometry in MAXI J1535-571 with Insight-HXMT and NICER 期刊论文  OAI收割 ASTROPHYSICAL JOURNAL, 2023, 卷号: 953, 期号: 2, 页码: 12 作者:  Yu, Wei;  Bu, Qing-Cui;  Liu, He-Xin;  Huang, Yue;  Zhang, Liang   |  收藏  |  浏览/下载：11/0  |  提交时间：2023/11/14 Absorption, distribution, metabolism, and excretion of [C-14]TPN729 after oral administration to rats 期刊论文  OAI收割 XENOBIOTICA, 2022, 页码: 12 作者:  Cheng, Huan;  Yu, Jinghua;  Yang, Chen;  Zhang, Ning;  Fan, Zhen   |  收藏  |  浏览/下载：29/0  |  提交时间：2022/06/15 TPN729  [C-14]TPN729  mass balance  tissue distribution  metabolism   LAMOST Time-Domain survey: first results of four K2 plates 期刊论文  OAI收割 RESEARCH IN ASTRONOMY AND ASTROPHYSICS, 2021, 卷号: 21, 期号: 11 作者:  Wang, Song;  Zhang, Hao-Tong;  Bai, Zhong-Rui;  Yuan, Hai-Long;  Xiang, Mao-Sheng   |  收藏  |  浏览/下载：89/0  |  提交时间：2022/01/11 astronomical database  miscellaneous  catalogs  stars  fundamental parameters  binaries  general  binaries  spectroscopic   Effect of autoinduction and food on the pharmacokinetics of furmonertinib and its active metabolite characterized by a population pharmacokinetic model 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2021, 页码: 10 作者:  Zou, Hui-xi;  Zhang, Yu-feng;  Zhong, Da-fang;  Jiang, Yong;  Liu, Fei   |  收藏  |  浏览/下载：76/0  |  提交时间：2022/01/04 furmonertinib  autoinduction  food effect  alkaline phosphatase  body weight  pharmacokinetics  modeling and simulation  NSCLC   Effects of Food on the Pharmacokinetic Properties and Mass Balance of Henagliflozin in Healthy Male Volunteers 期刊论文  OAI收割 CLINICAL THERAPEUTICS, 2021, 卷号: 43, 期号: 9, 页码: E264-E273 作者:  Chen, Zhen-dong;  Chen, Qian;  Zhu, Yun-ting;  Zhang, Yi-fan;  Zhan, Yan   |  收藏  |  浏览/下载：46/0  |  提交时间：2022/01/04 henagliflozin  food effects  mass balance  pharmacokinetics  SGLT-2 inhibitor   Furmonertinib (Alflutinib, AST2818) is a potential positive control drug comparable to rifampin for evaluation of CYP3A4 induction in sandwich-cultured primary human hepatocytes 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2021, 页码: 10 作者:  Wu, Ya-li;  Xue, Ya-ru;  Guo, Zi-tao;  Chen, Zhen-dong;  Ge, Xin-yu   |  收藏  |  浏览/下载：48/0  |  提交时间：2021/08/17 furmonertinib (alflutinib  AST2818)  quantitative proteomics  sandwich-cultured human hepatocytes   Simultaneous determination of forsythin and its major metabolites in human plasma via liquid chromatography-tandem mass spectrometry 期刊论文  OAI收割 JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2021, 卷号: 198, 页码: 7 作者:  Pan, Lu-lu;  Chen, Tao;  Hui, Min;  Wang, Shuo;  Fu, Li   |  收藏  |  浏览/下载：64/0  |  提交时间：2021/05/24 LC-MS/MS  Forsythin  Aglycone glucuronide  Aglycone sulfate  Pharmacokinetics   Taiji program in space for gravitational universe with the first run key technologies test in Taiji-1 期刊论文  OAI收割 INTERNATIONAL JOURNAL OF MODERN PHYSICS A, 2021, 卷号: 36, 期号: 11N12, 页码: 2 作者:  Wu YL(吴岳良);  Luo ZR(罗子人);  Wang, Jian-Yu;  Bai, Meng;  Bian, Wei   |  收藏  |  浏览/下载：134/0  |  提交时间：2021/06/21 Metabolic disposition of the EGFR covalent inhibitor furmonertinib in humans 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2021, 页码: 10 作者:  Meng, Jian;  Zhang, Hua;  Bao, Jing-jing;  Chen, Zhen-dong;  Liu, Xiao-yun   |  收藏  |  浏览/下载：69/0  |  提交时间：2021/06/11 metabolism  mass balance  distribution  covalent binding  furmonertinib   Metabolic disposition of the EGFR covalent inhibitor furmonertinib in humans 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2021, 页码: 10 作者:  Meng, Jian;  Zhang, Hua;  Bao, Jing-jing;  Chen, Zhen-dong;  Liu, Xiao-yun   |  收藏  |  浏览/下载：61/0  |  提交时间：2021/06/11 metabolism  mass balance  distribution  covalent binding  furmonertinib